Repros Therapeutics (RPRX)

8.34 +0.07 +0.85% May 31, 8:00PM Go Pro

Watch this stock

Repros Therapeutics Market Cap: 122.67M

Add a financial metric

Switch to
Select a metric

View As % Change
Show US Recessions

Zoom:
1d
5d
1m
3m
6m
YTD
1y
5y
10y
Max

Date range: to

<Embed Chart> Pro Save as Image Pro Data Export

Attention OK

RPRX Market Cap Rankings

Overall	26th percentile	3439 of 4664
Sector	35th percentile	342 of 527 in Healthcare
Industry	39th percentile	99 of 164 in Biotechnology

RPRX Market Cap Range, Past 5 Years

Minimum	11.42M	Jun 2010
Maximum	159.50M	Jun 2007
Average	79.34M

About Market Capitalization

Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.

For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.

There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More

You may also be interested in these RPRX related companies

Options

RPRX News

One Biotech That Defies Sensible Fundamentals
May 31, 3:44PM

$RPRX will hold on just enough to convince u no sell off comin. when u least expect it, floor may become sinkhole.2 words: Liver Toxicity
about a day ago by ninanina65

InPlay: Repros Therapeutics correction: Co updates status of Proellex clinical programs; FDA requests review of all oral data prior to initiation of additional oral studies
May 30, 6:55AM

Repros says FDA needs Proellex safety analysis
May 29, 5:55PM

Repros: FDA requests review of oral data prior to starting more oral studies
May 29, 4:28PM

REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events
May 29, 4:19PM

Repros Updates Status of Proellex Clinical Programs; Phase 2 Vaginal Proellex®-V, ZPV-200, Study on Track for Full Enrollment by End of June
May 29, 4:04PM Benzinga

FDA Says Repros Therapeutics (RPRX) Must Complete Integrated Safety Analysis of Oral Proellex
May 29, 4:03PM Street Insider

Repros Updates Status of Proellex(R) Clinical Programs
May 29, 4:01PM GlobeNewswire

$RPRX ez short
about 3 days ago by johnkelly

$ROSG blowing up again, $GNOM $RPRX $CIGX sympathy plays.
about 3 days ago by Billybob_TX

5/29 Watch List: $GNOM $RVBD $FRO $GTAT $LEAP $UPI $CECO $ITMN $MITK $RPRX $OSG $BV $POST $NUAN $MFRM
about 4 days ago by MatthewEagen

$RPRX - Trade Signal New - BTO @ 9.01-Limit w/6.55-Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/8ac9pbe
about 4 days ago by TraderFoxxx

Biotech Hedge Fund Bought This Surging Stock, And Other 13D/G Filings Last Week
May 27, 2:03PM

RT @TechEdgeTrades $RPRX keep it on ur radar.Could move quickly. Something behind all the insider buying http://stks.co/3zt9 all over itTNX
about 6 days ago by Tango13

$RPRX keep it on ur radar.Play it smart.Could move quickly. Something behind all the insider buying http://chart.ly/6sqfmh3
about 6 days ago by TechEdgeTrades

$RPRX Lots of insider buying.Short term tgt 11.10 Break res at 10.11 could make a quick move to 24 http://chart.ly/llny4yy
about 6 days ago by TechEdgeTrades

@YngvaiMalmsteve I see a record of a reverse split on Oct15 2010 chart shows a high of 57 on 8/31/07 $RPRX http://chart.ly/iac2rul
about 6 days ago by TechEdgeTrades

$RPRX saw that coming, but now will wait for the swing short, too focused w/ KV.A up 58% intraday
about 6 days ago by HighGrowthFinancial

@TechEdgeTrades $RPRX wasn't truly a $54 stock back in 2007...it was actually around $15...it's just done some reverse splits
about 6 days ago by YngvaiMalmsteve

$RPRX was on my radar but didn't pull the trigger,MACD still diverging.Was $54 stock back in 2007 http://chart.ly/qiddnhn
about 6 days ago by TechEdgeTrades

Notable 52-Week Highs and Lows of the Day 05/25: (LCC) (RPRX) High; (DCTH) (MXWL) (VIP) Low
May 25, 3:09PM Street Insider

Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower
May 25, 1:42PM Street Insider

$ROSG $RPRX - And they're off, check out $GNOM breaking above $3
about 7 days ago by slimtrader

RT @slimtrader $RPRX - Looks like $GNOM setting up for a run on 5min chart < Told ya
about 7 days ago by slimtrader

$RPRX - Looks like $GNOM setting up for a run on 5min chart
about 7 days ago by slimtrader

Sold $RPRX 9.75 from 8.98. Taking profits while I can.
about 7 days ago by Sigtau22

$RPRX Ripping again!
about 7 days ago by Sigtau22

VeriFone Systems, Quest Software, Other Stocks Hit 52-Week Highs Friday
May 25, 12:32PM Fox Business

$RPRX What a beast today!
about 7 days ago by Sigtau22

$RPRX taking a breather before push higher
about 7 days ago by Sigtau22

$RPRX ripping.
about 7 days ago by 228investing

$RPRX broke 8.50, could blow here.
about 7 days ago by 228investing

$RPRX New 52 Week High - Crossed daily highs resistance.
about 7 days ago by TradeIdeasQuant

4 Highly Liquid Biotech Stocks Being Snapped Up By Insiders
May 25, 1:51AM

$RPRX man thought this would have came back already,it will to,when?lesson not to short stocks that trade thin,this could see $10 easy
about 7 days ago by HighGrowthFinancial

5/25 Watch List: $TSL $STRI $RPRX $AMBT $ROSG $LCC $UAL $IAG $AMRN $YOKU $YPF $XPO
about 7 days ago by MatthewEagen

$GENE http://stks.co/3yyR $ROSG $GENE $RPRX $GNOM $TELK Full blog post here http://stks.co/3yyS
about 7 days ago by LincolnList

Repros Therapeutics (RPRX) Modifies Pivotal Androxal Protocol
May 22, 4:05PM Street Insider

Repros Updates Special Protocol Assessment Documentation for Pivotal Studies for Androxal
May 22, 4:05PM Benzinga

REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events
May 22, 4:03PM

Repros Updates Special Protocol Assessment Documentation for Pivotal Studies for Androxal(R)
May 22, 4:01PM GlobeNewswire

The Strongest Small-Caps in the Market
May 21, 4:04PM Benzinga

REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events
May 16, 4:06PM

Repros (RPRX) Gets Confirmation that Required Androxal Phase 3 Documents Delivered
May 16, 4:03PM Street Insider

FDA Receives Repros' Submission for Special Protocol Assessment Documentation for Pivotal Studies for Androxal
May 16, 4:01PM Benzinga

FDA Receives Repros' Submission for Special Protocol Assessment Documentation for Pivotal Studies for Androxal(R)
May 16, 4:01PM GlobeNewswire

5 Stocks That Insiders Love Right Now
May 16, 12:13PM

REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition
May 15, 9:27AM

Repros Therapeutics Inc.(R) Reports First Quarter 2012 Financial Results
May 15, 9:25AM GlobeNewswire

Top Insider Trades May 14, 2012: Repros
May 15, 3:02AM

Advance Auto Parts, InterOil Corporation Among Stocks Down on High Volume Monday
May 14, 12:56PM

Insiders Trading GHDX, PDH, RPRX
May 14, 9:42AM

Nasdaq stocks posting largest volume increases
May 10, 6:03PM

Unusual 11 Mid-Day Movers 05/10: (ADY) (INSP) (RPRX) Higher; (SGI) (WFR) (ARX) Lower
May 10, 2:24PM Street Insider

8 Stocks Under $10 Soaring Higher
May 10, 1:16PM

Monster Beverage, AMC Networks Among Stocks Gapping Up Thursday
May 10, 10:31AM Fox Business

REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events
May 09, 4:05PM

FDA and Repros Reach Agreement for Androxal Registration Program
May 09, 4:04PM Benzinga

FDA and Repros Reach Agreement for Androxal(R) Registration Program
May 09, 4:01PM GlobeNewswire

REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events
Apr 30, 4:04PM

Repros' Proellex(R)-V Clears Important Hurdle in Uterine Fibroid Program
Apr 30, 4:02PM GlobeNewswire

UPDATE: Ascendiant Initiates Coverage on Repros Therapeutics
Apr 10, 8:19AM Benzinga

Coverage initiated on Repros Therapeutics by Ascendiant Capital Markets
Apr 09, 6:24PM

Ascendiant Capital Starts Repros Therapeutics (RPRX) at Strong Buy; Advancing Two Products Into Phase 3 Makes Shares Attractive
Apr 09, 4:14PM Street Insider

Repros Therapeutics initiated with a Strong Buy at Ascendiant Capital
Apr 09, 3:55PM

REPROS THERAPEUTICS INC. Financials
Mar 31, 1:04PM

New Star Analyst Rankings for Repros Therapeutics Inc.
Mar 28, 9:51AM

REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition
Mar 27, 9:27AM

Repros Therapeutics, Inc. (RPRX) Tops Q4 EPS by 6c
Mar 27, 9:27AM Street Insider

Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2011 Financial Results
Mar 27, 9:25AM GlobeNewswire

Repros Therapeutics (RPRX) Announces FDA Meeting to Discuss Phase 3 Efficacy Studies of Androxal
Feb 27, 4:05PM Street Insider

REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events
Feb 27, 4:04PM

FDA Grants Repros Meeting to Discuss Androxal Phase 3 Study Design and Required Drug Dossier for NDA
Feb 27, 4:02PM Benzinga

FDA Grants Repros Meeting to Discuss Androxal(R) Phase 3 Study Design and Required Drug Dossier for NDA
Feb 27, 4:02PM GlobeNewswire

Recent Quotes

Symbol	Price	Chg	Chg %	Market Cap
RPRX	8.34	+0.07	+0.85%	122.23M
RPM	26.36	-0.02	-0.08%	3.463B
REFR	3.39	+0.07	+2.11%	62.78M
REE	4.07	-0.20	-4.68%	188.86M
REDF	4.21	-0.38	-8.28%	134.17M
RE	102.12	+0.90	+0.89%	5.440B
QPSA	2.93	-0.06	-2.01%	108.24M
QMM	0.44	+0.01	+1.15%	66.26M
QLTY	10.62	+0.23	+2.21%	280.22M
QLTI	7.61	+0.03	+0.40%	371.12M

Create Watchlist from Stock Quotes